From: CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway
Antibodies | Source | identifier |
---|---|---|
Anti-beta Actin antibody | Abcam | Cat#ab8227 |
GRO alpha Rabbit pAb | ABclonal | Cat#A5802 |
CXCR2 Rabbit pAb | ABclonal | Cat#A3301 |
Phospho-IκBα Rabbit mAb | Cell Signaling Technology | Cat#2859 |
IκBα Rabbit mAb | Cell Signaling Technology | Cat#4812 |
Phospho-NF-κB p65 Rabbit mAb | Cell Signaling Technology | Cat#3033 |
NF-κB p65 Rabbit mAb | Cell Signaling Technology | Cat#8242 |
Anti-CD31 antibody | Abcam | Cat#ab9498 |
Anti-CD4 antibody | Abcam | Cat#ab183685 |
Anti-CD8 antibody | Abcam | Cat#ab217344 |
Anti-CD163 antibody | Abcam | Cat#ab182422 |
Donkey Anti-Rabbit IgG H&L | Abcam | Cat#ab150075 |
DAPI | ZSGB-BIO | Cat#ZLI-9557 |